Crown Bioscience is a leading global Contract Research Organization (CRO) specializing in preclinical and translational platforms for oncology, immuno-oncology, and inflammatory diseases. They offer high-quality in vivo, in vitro, and ex vivo models, providing comprehensive solutions for pharmaceutical companies in their drug development processes. Established in 2006, Crown Bioscience focuses on delivering innovative, reliable, and efficient services that meet the evolving demands of the pharmaceutical industry.

Services include:
- Animal Model Services
- Assay Development
- Bioanalytical Services
- Bioavailability Studies
- Biomarker Research
- Cell Culture Media Development
- Chemistry (CMC)
- Medicinal
- Contract Research (CRO)
- Drug Design
- Drug Development
- Contract Development
- Efficacy Testing
- Fragment-Based Screening
- Genomics and Screening
- In Vitro Testing
- Testing
- Metabolic Analysis
- Nonclinical Research
- Pharmacogenomics
- Pharmacokinetics
- Pharmacology
- Preclinical Study Design
- Preclinical Testing
- Process Development
- Protein Extraction/Purification
- Purification
- R&D Services
- Scale-Up
- Stem Cells
- Translation Services
- X-Ray Crystallography

Crown Bioscience continues to advance the field of drug development by offering an extensive range of services tailored to meet the needs of their clients. For more information, please visit crownbio.com.